What You Should Know:

您应该知道：

–              SmarterDx, the leader in clinical AI for revenue integrity and care quality, today announced it has secured $50 million in Series B funding led by Transformation Capital.

–SmarterDx是临床人工智能在收入完整性和护理质量方面的领导者，今天宣布它已经获得了由Transformation Capital牵头的5000万美元的B系列资金。

–              The round also includes continued investments from Bessemer Venture Partners, Flare Capital Partners and Floodgate Fund, bringing total funding to $71 million to date. The investment will drive product innovation that will create additional value for health systems, as well as support scale as the company expands. .

–本轮投资还包括Bessemer Venture Partners、Flare Capital Partners和Floodgate Fund的持续投资，迄今为止，总资金已达到7100万美元。该投资将推动产品创新，为卫生系统创造额外价值，并随着公司的扩张支持规模。。

SmarterDx: Revolutionizing Healthcare Revenue Cycle Solutions with Clinical AI

SmarterDx：通过临床AI彻底改变医疗保健收入周期解决方案

SmarterDx, which secured seed funding in 2022, utilizes clinical AI that uniquely comprehends clinical reasoning and offers complete auditability, empowering health systems to address their revenue integrity gap. Minor errors or omissions in clinical documentation can result in overlooked, rejected, or underpaid claims.

SmarterDx于2022年获得种子资金，利用临床人工智能独特地理解临床推理并提供完整的可审计性，使卫生系统能够解决其收入完整性差距。临床文件中的微小错误或遗漏可能导致索赔被忽视，被拒绝或报酬不足。

SmarterDx addresses this issue by conducting second-level reviews of each patient chart, enabling hospitals and health systems to protect millions in revenue leakage and ensure accurate representation of care quality..

SmarterDx通过对每个患者图表进行二级审查来解决这个问题，使医院和卫生系统能够保护数百万收入流失，并确保准确反映护理质量。。

With this investment, SmarterDx will incorporate new clinical and financial data integrations and continue refining its proprietary algorithms that pinpoint new revenue and quality enhancement opportunities for clients. On average, SmarterDx identifies $2 million in net new annual revenue per 10,000 patient discharges for its clients, which encompass some of the largest hospitals and health systems nationwide.

通过这项投资，SmarterDx将整合新的临床和财务数据集成，并继续改进其专有算法，为客户确定新的收入和质量提升机会。平均而言，SmarterDx为其客户确定了每10000名患者出院的净年收入200万美元，其中包括全国最大的一些医院和卫生系统。

With a client retention rate of 100%, a 5:1 return on investment, and a KLAS client satisfaction score of 98, SmarterDx has rapidly emerged as a leader in the healthcare revenue cycle solutions market..

凭借100%的客户保留率、5:1的投资回报率和98分的KLAS客户满意度，SmarterDx迅速成为医疗保健收入周期解决方案市场的领导者。。

“SmarterDx transforms clinical data into insights that are fully attributable and actionable. This has distinguished our product in a healthcare landscape where many AI solutions have been built on hype, have poorly defined value and focus on replacing people,” said Dr. Michael Gao, co-founder and CEO of SmarterDx.

SmarterDx联合创始人兼首席执行官迈克尔·高博士表示：“SmarterDx将临床数据转化为完全可归因和可操作的见解。这使我们的产品在医疗保健领域脱颖而出，许多人工智能解决方案都是建立在炒作的基础上，价值定义不明确，专注于更换人员。”。

“Our focus has always been empowering clinical documentation integrity and coding teams to capture a more accurate, more complete patient picture and enabling providers to focus on patient care rather than paperwork.”.

“我们的重点一直是使临床文档完整性和编码团队能够捕获更准确，更完整的患者图片，并使提供者能够专注于患者护理而不是文书工作。”。